Stocks to Watch: Lucira Health, Tegna
February 24 2023 - 6:58PM
Dow Jones News
By Sabela Ojea
Lucira Health Inc. on Friday received the U.S. Food and Drug
Administration's emergency use authorization for its Covid-19 and
Flu diagnostic test. Shares of the company, which provides at-home
molecular tests and tele-health services for Covid-19, jumped 180%
in after-hours trading.
Tegna Inc.'s $5.4 billion proposed sale to hedge fund Standard
General L.P. will be further examined by an administrative law
judge, the U.S. Federal Communications Commission said. Shares of
the TV broadcaster dropped 26% in after-hours trading.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
February 24, 2023 18:43 ET (23:43 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jul 2023 to Jul 2024
